Cara Therapeutics, Inc. (CARA)
Company Info
ISIN | US1407551092 |
---|---|
CUSIP | 140755109 |
Sector | Healthcare |
Industry | Biotechnology |
Trading Data
Previous Close | $12.56 |
---|---|
Year Range | $7.45 - $18.14 |
EMA (50) | $9.65 |
EMA (200) | $11.01 |
Average Volume | $491.17K |
Market Capitalization | $603.97M |
CARAShare Price Chart
Click Calculate to get results
CARAPerformance
The chart shows the growth of $10,000 invested in Cara Therapeutics, Inc. in Feb 2014 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $9,729 for a total return of roughly -2.71%. All prices are adjusted for splits and dividends.
CARAReturns in periods
Period | Return | Benchmark |
---|---|---|
1M | 28.16% | 7.97% |
6M | 19.05% | -6.88% |
YTD | 3.12% | -11.66% |
1Y | 0.40% | -5.01% |
5Y | -1.94% | 11.56% |
10Y | -0.32% | 10.62% |
CARAMonthly Returns Heatmap
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2022 | -4.93% | -10.45% | 17.16% | -28.23% | -4.59% | 9.74% | -4.27% | 43.71% | ||||
2021 | 23.60% | -1.87% | 18.31% | -40.35% | 4.94% | 5.00% | -16.12% | 31.83% | -2.09% | 8.93% | -21.69% | -7.59% |
2020 | -0.06% | -6.65% | -12.11% | 12.19% | 7.09% | 7.75% | -3.86% | -5.72% | -17.90% | 4.20% | 10.63% | 3.14% |
2019 | 17.31% | 11.80% | 15.07% | -2.75% | 7.76% | 4.57% | 11.35% | -2.09% | -22.01% | 13.57% | 25.14% | -37.99% |
2018 | 19.85% | -4.70% | -11.44% | 0.00% | 26.33% | 22.44% | -6.37% | 12.49% | 18.74% | -21.75% | -2.99% | -28.49% |
2017 | 64.91% | 4.63% | 14.72% | -13.59% | 4.22% | -7.07% | -8.77% | 2.07% | -4.47% | -8.40% | -0.72% | -1.69% |
2016 | -46.62% | -45.33% | 26.42% | -1.93% | 5.90% | -25.54% | 23.28% | -8.60% | 54.06% | -16.29% | 28.76% | 3.22% |
2015 | 8.22% | -5.00% | -1.95% | 6.97% | -11.44% | 27.63% | 75.39% | -11.03% | -24.63% | -0.84% | 16.80% | 1.87% |
2014 | 46.24% | -1.43% | -22.68% | -4.24% | 23.51% | -25.09% | -19.84% | -17.91% | 7.39% | 2.55% | 7.90% |
CARADividend History
Cara Therapeutics, Inc. doesn't pay dividends
CARADrawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
CARAWorst Drawdowns
The table below shows the maximum drawdowns of the Cara Therapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.
The maximum drawdown since January 2010 for the Cara Therapeutics, Inc. is 80.50%, recorded on Jun 27, 2016. It took 251 trading sessions for the portfolio to recover.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
---|---|---|---|---|---|---|
-80.5% | Aug 6, 2015 | 225 | Jun 27, 2016 | 251 | Jun 26, 2017 | 476 |
-74.48% | Apr 12, 2021 | 273 | May 9, 2022 | — | — | — |
-66.16% | Jun 29, 2017 | 684 | Mar 18, 2020 | 264 | Apr 6, 2021 | 948 |
-65.5% | Mar 6, 2014 | 161 | Oct 22, 2014 | 197 | Aug 5, 2015 | 358 |
-17.89% | Feb 3, 2014 | 3 | Feb 5, 2014 | 3 | Feb 10, 2014 | 6 |
-4.33% | Feb 19, 2014 | 1 | Feb 19, 2014 | 1 | Feb 20, 2014 | 2 |
-3.87% | Feb 11, 2014 | 1 | Feb 11, 2014 | 4 | Feb 18, 2014 | 5 |
-3.47% | Feb 24, 2014 | 1 | Feb 24, 2014 | 2 | Feb 26, 2014 | 3 |
-2.28% | Apr 7, 2021 | 1 | Apr 7, 2021 | 1 | Apr 8, 2021 | 2 |
CARAVolatility Chart
Current Cara Therapeutics, Inc. volatility is 87.22%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.